TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion.
about
TWEAK/Fn14 Activation Participates in Skin Inflammation.Phase 1 study of enavatuzumab, a first-in-class humanized monoclonal antibody targeting the TWEAK receptor, in patients with advanced solid tumors.Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-κB axis.Involvement of TWEAK and the NF-κB signaling pathway in lupus nephritis.Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.
P2860
TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
TWEAK activation of the non-ca ...... prostate cancer cell invasion.
@en
TWEAK activation of the non-ca ...... prostate cancer cell invasion.
@nl
type
label
TWEAK activation of the non-ca ...... prostate cancer cell invasion.
@en
TWEAK activation of the non-ca ...... prostate cancer cell invasion.
@nl
prefLabel
TWEAK activation of the non-ca ...... prostate cancer cell invasion.
@en
TWEAK activation of the non-ca ...... prostate cancer cell invasion.
@nl
P2093
P2860
P356
P1433
P1476
TWEAK activation of the non-ca ...... prostate cancer cell invasion.
@en
P2093
Cheryl L Armstrong
Jeffrey A Winkles
Rebeca Galisteo
Sharron A N Brown
P2860
P304
81474-81492
P356
10.18632/ONCOTARGET.13034
P407
P577
2016-11-03T00:00:00Z